XT
PAVM icon

XTX Topco’s PAVmed PAVM Stock Holding History

XTX Topco’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,391
Closed -$9.21K – 4228
2025
Q4 		$9.21K Buy
1,391
+981
+239% +$11.2K ﹤0.01% 3189
2025
Q3 		$5.33K Buy
+410
New +$6.09K ﹤0.01% 2466
2025
Q2 		– Sell
-781
Closed -$16.9K – 2961
2025
Q1 		$16.9K Buy
+781
New +$16.2K ﹤0.01% 2179
2023
Q4 		– Sell
-73
Closed -$9.63K – 1979
2023
Q3 		$9.63K Buy
+73
New +$11.3K ﹤0.01% 1423
2022
Q2 		– Sell
-33
Closed -$19K – 1042
2022
Q1 		$19K Sell
33
-60
-65% -$44.6K 0.01% 630
2021
Q4 		$103K Buy
+93
New +$202K 0.06% 463

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's PAVM Position: Q1 2026 in Review

XTX Topco sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 1,391 shares — an estimated $9.21K sold.

XTX Topco first reported a position in PAVM in Q4 2021 and held it in 6 quarters. The position peaked at $103K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • XTX Topco reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 1,391 PAVmed shares in Q1 2026, an estimated $9.21K.
  • XTX Topco first reported a position in PAVmed in Q4 2021 and held it in 6 quarters.
  • XTX Topco's PAVmed position peaked at $103K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.